Page last updated: 2024-12-11

flavokawain a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

flavokawain A: from kava extract, induces apoptosis in bladder cancer cells; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5355469
CHEMBL ID243829
CHEBI ID157725
SCHEMBL ID2289181
SCHEMBL ID2289188
MeSH IDM0485381

Synonyms (40)

Synonym
nsc37445
nsc-37445
mls002608040 ,
3420-72-2
(e)-1-(2-hydroxy-4,6-dimethoxy-phenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
2'-hydroxy-4,4',6'-trimethoxychalcone
2'-hydroxy-4,4',6'-trimethoxychalcone, 98%
flavokawain a
smr001490973
CHEMBL243829
(e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
CHEBI:157725
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
(2e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
bdbm50360495
flavokavain a
37951-13-6
AKOS015915333
S5600
64680-84-8
flavokavin a
SCHEMBL2289181
SCHEMBL2289188
CGIBCVBDFUTMPT-RMKNXTFCSA-N
2-propen-1-one, 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)-
AS-72376
CS-0022627
HY-N2420
J-019499
mfcd00017174
Q5458164
(2e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)-2-propen-1-one
4-methoxyflavokawain b
unii-8om2xz2zm3
2-propen-1-one, 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)-, (2e)-
8om2xz2zm3 ,
CCG-267628
flavokavain a(p)
A875070
DTXSID601317535

Research Excerpts

Overview

Flavokawain A is a chalcone found in the kava-kava plant (Piper methsyticum)

ExcerptReferenceRelevance
"Flavokawain A is a chalcone that can be found in the kava-kava plant (Piper methsyticum) extract. "( In Vivo Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice.
Abdullah, MP; Abu, N; Akhtar, MN; Alitheen, NB; Kee, BB; Lim, KL; Mohamed, NE; Omar, AR; Yeap, SK; Zulfadli, AJ, 2015
)
2.15

Effects

ExcerptReferenceRelevance
"Flavokawain A has beneficial effects on the surgically induced endometriosis rat model, by reducing inflammation, promoting apoptosis, and decreasing angiogenesis. "( Beneficial biological effects of Flavokawain A, a chalcone constituent from kava, on surgically induced endometriosis rat model.
Chen, Y; Cheng, R; Gu, X; Hu, D; Jiang, T; Miao, M; Teichmann, AT; Wei, Z; Yang, Y; Zhang, J; Zhou, H, 2024
)
3.17

Toxicity

ExcerptReferenceRelevance
" This adverse potential has never been captured in animal models, and the responsible compound(s) remains to be determined."( Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice.
Leitzman, P; Narayanapillai, SC; O'Sullivan, MG; Xing, C, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)IC50 (µMol)4.41500.00401.966610.0000AID638477; AID638478
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
lipid transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid biosynthetic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate metabolic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transmembrane transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transepithelial transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
renal urate salt excretionBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
export across plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
cellular detoxificationBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ABC-type xenobiotic transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
efflux transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP hydrolysis activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATPase-coupled transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
identical protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
protein homodimerization activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
nucleoplasmBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
brush border membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrial membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
membrane raftBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
external side of apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (68)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID391019Cytotoxicity against human DU145 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID391020Cytotoxicity against human MCF7 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID452852Antioxidant activity assessed as hydroxyl radical scavenging activity at 100 uM2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID1420056Inhibition of PRAK (unknown origin) at 50 uM2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
AID452853Antioxidant activity assessed as hydrogen peroxide scavenging activity by peroxyoxalate chemiluminescent method2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID638550Inhibition of MDR1 in human A2780adr cells assessed as calcein AM accumulation at 10 uM by fluorimetry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.
AID391024Cytotoxicity against human K562 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID452849Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM after 20 mins2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID391022Cytotoxicity against human HT29 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID452851Antioxidant activity assessed as superoxide anion radical scavenging activity at 10 uM2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID391017Cytotoxicity against BALB mouse 3T3 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID452850Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM after 60 mins2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID1427261Cytotoxicity against human HaCaT cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427258Cytotoxicity against human HCT116 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID447711Inhibition of TNF-alpha-induced NF-kappaB expressed in human A549 cells treated 1 hr after TNFalpha challenge measured after 6 hrs by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID452848Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM after 60 mins2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID1190838Inhibition of mushroom tyrosinase using L-tyrosine as substrate after 20 mins by microplate reader2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.
AID638551Inhibition of MRP1 overexpressed in human 2008 MRP1 cells assessed as calcein AM accumulation at 10 uM by fluorimetry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.
AID1361618Inhibition of human MDM2-p53 interaction in Saccharomyces cerevisiae assessed as p53 induced cell growth arrest at 1 to 50 uM after 42 hrs by Yeast-based assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
AID1698234Effect on cell viability in human neutrophils assessed as decrease in cell viability at 3.1 uM after 1 hr by Propidium staining based flow cytometric analysis2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID391023Cytotoxicity against human PC3 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID443496Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by luciferase reporter gene assay2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
AID452847Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM after 20 mins2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID598368Antifungal activity against Aspergillus niger ATCC 16404 after 48 hrs by broth microdilution technique2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and antifungal activities of natural and synthetic biflavonoids.
AID551962Inhibition of cobalt chloride-induced HIF-1 activation expressed in mouse NIH3T3 cells after 8 hrs by luciferase reporter gene assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID1420024Inhibition of DYRK1A (unknown origin) at 50 uM2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
AID638477Inhibition of BCRP in human MCF7/MX cells assessed as Hoechst 33342 accumulation preincubated for 30 mins by Fluorometry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.
AID1361621Growth inhibition of Saccharomyces cerevisiae expressing p53 at 1 to 50 uM after 42 hrs by Yeast-based assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
AID391018Cytotoxicity against human H460 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID391026Cytotoxicity against african green monkey Vero cells by MTT assay2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID1361620Growth inhibition of Saccharomyces cerevisiae expressing empty vector at 1 to 50 uM after 42 hrs by Yeast-based assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
AID1190839Antimelanogenic activity in mouse B16F10 cells assessed as inhibition of melanin production after 4 days2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.
AID1737236Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells at 10 uM measured after 24 hrs by Griess reagent based assay relative to control2020European journal of medicinal chemistry, May-01, Volume: 193Development of a novel nitric oxide (NO) production inhibitor with potential therapeutic effect on chronic inflammation.
AID295380Cytotoxicity against human TK10 cells in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID391021Cytotoxicity against human M14 cells after 48 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID1427255Cytotoxicity against human HuH7 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1698240Inhibition of PMA-induce ROS/RNS generation in human neutrophils at 3.1 uM measured up to 30 mins in presence of 5.5 mM glucose by luminol-amplified chemiluminescence method relative to control2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID1100871Antifeedant activity against Spodoptera litura in compound treated cork borer from fresh sweet potato leaves by Choice Leaf-Disk Bioassay2000Journal of agricultural and food chemistry, May, Volume: 48, Issue:5
Insect antifeedant flavonoids from Gnaphalium affine D. Don.
AID295382Cytotoxicity against human HT29 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID452856Inhibition of soybean 5-lipoxygenase at 100 uM by UV-absorbance based enzyme assay2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID1427257Cytotoxicity against human MDA-MB-231 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID452854Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 10 uM by uV spectrophotometry2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID391025Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C4 in african green monkey Vero cells after 120 hrs2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
AID452948Toxicity against BALB/c mouse macrophage by MTT assay2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID638478Inhibition of human BCRP expressed in MDCK2 cells assessed as Hoechst 33342 accumulation preincubated for 30 mins by fluorimetry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.
AID447716Hepatotoxicity against mouse Hepa-1c1c7 cells after 48 hrs by celltiter blue assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1427256Cytotoxicity against human Caco2 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1361600Antiproliferative activity against human HCT116 cells after 48 hrs by SRB assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
AID1427260Cytotoxicity against human NCI-H727 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427262Cytotoxicity against human fibroblasts assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1361622Growth inhibition of Saccharomyces cerevisiae expressing MDM2 at 1 to 50 uM after 42 hrs by Yeast-based assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
AID551964Cytotoxicity against mouse NIH/3T3 cells assessed as cell viability after 8 hrs2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID452945Antileishmanial activity against Leishmania amazonensis MHOM/BR/76/LTB-012 amastigotes infected in mouse macrophage by MTT assay2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones.
AID1420057Inhibition of aurora B (unknown origin) at 50 uM2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
AID295381Cytotoxicity against human MCF7 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID1698245Inhibition of PMA-induce ROS/RNS generation in human neutrophils at 3.1 uM measured up to 30 mins in presence of 30 mM glucose by luminol-amplified chemiluminescence method relative to control2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID1427259Cytotoxicity against human PC3 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (21.74)29.6817
2010's25 (54.35)24.3611
2020's11 (23.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.48 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.69 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (97.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]